Q1 2023
Released Apr 4, 2023, after the close
10-Q filed May 10, 2023, 40 days after period end · 0001493152-23-016161
Q1 2023 · 10-Q
Revenue$3.70M$3.70M +71.2% vs Q1 2022+44.6% vs Q4 2022
Net Income-$306.00K-$306.00K N/M vs Q1 2022N/M vs Q4 2022
EPS Diluted-$0.03-$0.03 no prior Q1 2022 on fileno prior Q4 2022 on file
Gross Profit$2,111,000+100.5%
Operating Income-$306,000N/M
Operating Cash Flow$276,000N/M
Margins · derived
Gross margin57.1%+8.3 pt vs Q1 2022
Operating margin-8.3%+63.4 pt vs Q1 2022
Net margin-8.3%+82.8 pt vs Q1 2022
What the release said
The release
Same quarter
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $3.70M | $2.16M | $2.74M | $2.53M |
| Net Income | -$306.00K | -$1.97M | -$537.00K | -$1.10M |
| EPS Diluted | -$0.03 | — | -$0.06 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR